Hold. BZ scores elite on Growth Compounder (82/100) with strong revenue momentum, but Leadership Alignment lags at 52/100—suggesting misalignment between founder incentives and shareholder returns. The critical constraint: Vulnerability Index of 100/100 reflects a thin financial buffer with limited runway for adverse shocks. At 12.0× forward P/E, valuation offers modest margin of safety, but execution risk outweighs growth tailwinds until management alignment improves.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for KANZHUN LIMITED - American Depo:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 71/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates KANZHUN LIMITED - American Depo (BZ) at 71/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. BZ scores elite on Growth Compounder (82/100) with strong revenue momentum, but Leadership Alignment lags at 52/100—suggesting misalignment between founder incentives and shareholder returns. The critical constraint: Vulnerability Ind
BZ's current Stocky Verdict is 71/100, placing it in the "Hold" band. This composite combines a 82/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for KANZHUN LIMITED - American Depo yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
KANZHUN LIMITED - American Depo scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
KANZHUN LIMITED - American Depo's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to KANZHUN LIMITED - American Depo.
Sign up free and unlock the full analysis on BZ — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for BZ in the app.
